A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and...
The Veterans’ Health Administration will cover Eisai and Biogen‘s Alzheimer’s treatment Leqembi for some patients, the companies announced on Monday. In a statement, Eisai said veterans...
Andrew Brookes | Image Source | Getty Images The Food and Drug Administration will make a decision on whether to fully approve Eisai‘s and Biogen‘s Alzheimer’s...
Medicare will not provide broader coverage of the Alzheimer’s drug Leqembi until it receives more evidence that the treatment is reasonable and necessary, according to the...
U.S. senators on Friday called for Medicare to offer broad coverage of Alzheimer’s treatments approved by the Food and Drug Administration, warning that current restrictions cost...
Tek Image/science Photo Library | Science Photo Library | Getty Images Japanese drugmaker Eisai expects the Food and Drug Administration to fully approve its Alzheimer’s treatment...
MRI image of brain showing area of Alzheimer patient. Getty Images The Food and Drug Administration on Friday granted accelerated approval for the Alzheimer’s drug lecanemab,...
Investors looking to reposition their portfolios for 2023 may want to consider making bets on this assortment of stocks, according to Baird. Wall Street suffered a...
Check out the companies making headlines in midday trading Friday. Energy — Energy stocks outperformed on the S&P 500 following a rise in oil prices, which...
Check out the companies making headlines before the bell: Tesla (TSLA) – Tesla CEO Elon Musk said he would refrain from selling any more Tesla stock...
